Landmark PBS listing for Australians with cystic fibrosis
Australians with cystic fibrosis in Bonner will soon have access to a new treatment following the listing of Trikafta® on the Pharmaceutical Benefits Scheme (PBS). From April 1, Trikafta® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) will be available on the PBS for the first time for Australians with cystic fibrosis aged 12 years and older, who have at…
